Target intelligence / Profile preview

Neurotrimin (NTM)

Target
NTM
Molecular classification
Immunoglobulin superfamily, Cell adhesion molecule, Glycosylphosphatidylinositol (GPI)-anchored protein, IgLON family member
01

Overview

Neurotrimin is a glycosylphosphatidylinositol (GPI)-anchored cell adhesion molecule of the immunoglobulin superfamily and a member of the IgLON protein family (which also includes LSAMP, OBCAM, NEGR1, and IGLON5)[1][4][5]. It contains three immunoglobulin-like domains and functions at the neuronal cell surface, mediating cell–cell adhesion via homophilic and heterophilic dimerization[1][2][3]. Neurotrimin is implicated in the development of neural circuits by promoting neurite outgrowth, dendritic branching, and synapse formation, and its expression and genetics have been linked to cognitive function, intelligence, and several neuropsychiatric and neurodevelopmental disorders[1][3][4]. While NTM shares structural and functional similarities with other IgLONs, emerging studies indicate context-dependent roles in non-neural tissues, including involvement in metabolic regulation and hormone-dependent function[3]. Disease associations are inferred primarily from genetic studies, and there are not yet any drugs directly targeting neurotrimin.

Other names
NTMIGLON2NTUNQ297/PRO337hNTHNTNTRICEPU-1IgLON family member 2neurotrimin
02

Biological functions

Cell adhesionSynapse formationNeurite outgrowthDendritic developmentModulating neural circuitryAggregation of neural cellsCognitive function
03

Disease associations

Neuropsychiatric disorders (implicated via genetic studies)Cognitive disorders (linked to intelligence and cognitive phenotypes)Neurodevelopmental disorders (possibly autism spectrum disorders, Jacobsen syndrome)Alzheimer’s disease (GWAS association)Ovarian cancer (context-dependent expression)Metabolic regulation (implicated in lipid profiles via GWAS)
04

Safety considerations

Insufficient evidence for drug-related safety concernsDisruption may not always result in overt pathology, complicating disease association and target validation
05

Biomarkers

Genetic variants/SNPs in NTM (possible efficacy or risk markers in cognitive/neurodevelopmental studies)

Beyond the preview

Go deeper on Neurotrimin (NTM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurotrimin (NTM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call